Milestone Pharmaceuticals Inc. MIST
Set alert
0.74 USD +0.02 +3.19%
As of Nov 3, 1:52 PM ET
0.72 Day range 0.7661
0.631 52-week range 3.06
- YTD
- -63.16%
- 1 year
- -59.78%
- Open
- 0.72
- Prev close
- 0.7211
- Mkt cap
- 92.64M
- Vol
- 335.24K
- Avg vol
- 1.35M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.72
- High
- 0.7661
- Forward P/E
- -2.15
- Beta
- 1.73
- Short ratio
- 2.46
- Inst. own
- 57.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.71
- 200-d avg
- 1.58
- 1y target
- 10.25
30m chart
Built from the cached five-day intraday bars.
Signals (12)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 9:55 AM | 3 hours ago |
| SMA: Bullish | Nov 3, 9:55 AM | 3 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 1:55 PM | 23 hours ago |
| MACD: Buy Signal | Nov 2, 1:55 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 10:55 AM | 1 day ago |
| SMA: Bullish | Nov 2, 9:55 AM | 1 day ago |
| SMA: Bearish | Oct 30, 11:25 AM | 4 days ago |
| SMA: Bullish | Oct 30, 10:55 AM | 4 days ago |
| SMA: Bearish | Oct 29, 1:55 PM | 5 days ago |
Analyst view
Price target (mean) 10.25 +1277.5% upside
Now 0.7441
- Target (low)
- 2.00
- Target (mean)
- 10.25
- Target (high)
- 25.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
- Strong buy2
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.15 | -0.16 – -0.14 | -0.32 | +53.1% | 0 | 0.0% | 2 |
| Next quarter | -0.17 | -0.21 – -0.13 | -0.21 | +19.0% | 0 | 0.0% | 2 |
| Current year | -0.61 | -0.64 – -0.58 | -1.39 | +56.1% | 0 | -100.0% | 2 |
| Next year | -0.81 | -1.11 – -0.51 | -0.61 | -32.8% | 6.05M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 22, 2024 | Rodman & Renshaw | Initiated | — | Buy |
| Jul 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 5, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 27, 2023 | TD Cowen | Maintained | Outperform | Outperform |
| Aug 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 20, 2023 | Jefferies | Downgrade | Buy | Hold |
| May 23, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 12, 2023 | Oppenheimer | Maintained | — | Outperform |
| Mar 30, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 9, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 14, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 22, 2022 | Piper Sandler | Upgrade | Neutral | Overweight |
| Mar 5, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Jul 29, 2020 | Oppenheimer | Upgrade | Perform | Outperform |
| Jul 24, 2020 | Jefferies | Upgrade | Hold | Buy |
| Mar 25, 2020 | Jefferies | Downgrade | Buy | Hold |
| Mar 24, 2020 | Oppenheimer | Downgrade | Outperform | Perform |
| Mar 24, 2020 | Piper Sandler | Downgrade | Overweight | Neutral |
| Jun 3, 2019 | Jefferies | Initiated | — | Buy |
| Jun 3, 2019 | Piper Sandler | Initiated | — | Overweight |